Olympia Financial Group (TSE:OLY) Given a C$143.52 Price Target by Fundamental Research Analysts

Olympia Financial Group (TSE:OLYGet Free Report) received a C$143.52 target price from Fundamental Research in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The firm currently has a “buy” rating on the health services provider’s stock. Fundamental Research’s target price indicates a potential upside of 44.52% from the company’s current price.

Olympia Financial Group Stock Performance

TSE:OLY traded down C$0.59 during trading on Tuesday, reaching C$99.31. The company’s stock had a trading volume of 1,112 shares, compared to its average volume of 1,995. The company has a debt-to-equity ratio of 6.00, a quick ratio of 1.59 and a current ratio of 3.32. The firm has a 50 day moving average of C$108.00 and a 200-day moving average of C$104.04. Olympia Financial Group has a 12 month low of C$89.90 and a 12 month high of C$114.34. The firm has a market cap of C$238.97 million, a price-to-earnings ratio of 9.77 and a beta of 0.27.

Insider Activity

In related news, Director Anthony Lanzl sold 300 shares of the firm’s stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of C$107.54, for a total transaction of C$32,262.00. Over the last three months, insiders sold 710 shares of company stock worth $75,880. 34.63% of the stock is owned by corporate insiders.

About Olympia Financial Group

(Get Free Report)

Olympia Financial Group Inc, through its subsidiary, Olympia Trust Company, operates as a non-deposit taking trust company in Canada. The company operates through Investment Account Services, Currency and Global Payments, Private Health Services Plan, Exempt Edge, and Corporate and Shareholder Services divisions.

Featured Stories

Receive News & Ratings for Olympia Financial Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympia Financial Group and related companies with MarketBeat.com's FREE daily email newsletter.